China Pharma (NYSE:CPHI) Coverage Initiated by Analysts at StockNews.com

StockNews.com began coverage on shares of China Pharma (NYSE:CPHI) in a research report sent to investors on Thursday. The firm issued a hold rating on the stock.

China Pharma Price Performance

CPHI stock opened at $0.19 on Thursday. The company’s 50 day moving average is $0.23 and its 200 day moving average is $0.24. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.24 and a current ratio of 0.79. China Pharma has a 1-year low of $0.17 and a 1-year high of $1.16.

About China Pharma

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.